AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
ALLOGENEIC TRANSPLANTATION OF UNMANIPULATED PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: MAJOLINO I CORRADINI P SCIME R SANTORO A TARELLA C CAVALLARO AM PALUMBO A INDOVINA A CARACCIOLO D BOCCADORO M MARCENO R PILERI A
Citation: I. Majolino et al., ALLOGENEIC TRANSPLANTATION OF UNMANIPULATED PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH MULTIPLE-MYELOMA, Bone marrow transplantation, 22(5), 1998, pp. 449-455
G-CSF ADMINISTRATION FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFT IN LYMPHOID MALIGNANCIES - EVIDENCE FOR CLINICAL BENEFITS AND REDUCTION OF TREATMENT COSTS
Authors: TARELLA C CASTELLINO C LOCATELLI F CARACCIOLO D CORRADINI P FALDA M NOVARINO A TASSI V PILERI A
Citation: C. Tarella et al., G-CSF ADMINISTRATION FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFT IN LYMPHOID MALIGNANCIES - EVIDENCE FOR CLINICAL BENEFITS AND REDUCTION OF TREATMENT COSTS, Bone marrow transplantation, 21(4), 1998, pp. 401-407
A SINGLE-STEP DENSITY GRADIENT SEPARATION FOR LARGE-SCALE ENRICHMENT OF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS COLLECTED FOR AUTOTRANSPLANTATION
Authors: FERRERO D TARELLA C CHERASCO C BONDESAN P OMEDE P RAVAGLIA R CARACCIOLO D CASTELLINO C PILERI A
Citation: D. Ferrero et al., A SINGLE-STEP DENSITY GRADIENT SEPARATION FOR LARGE-SCALE ENRICHMENT OF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS COLLECTED FOR AUTOTRANSPLANTATION, Bone marrow transplantation, 21(4), 1998, pp. 409-413
PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR ALLOGENEIC TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)
Authors: MAJOLINO I TARELLA C SCIME R SANTORO A CORRADINI P CAVALLARO AM PALUMBO A INDOVINA A CARACCIOLO D BOCCADORO M MARCENO R PILERI A
Citation: I. Majolino et al., PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR ALLOGENEIC TRANSPLANTATION IN MULTIPLE-MYELOMA (MM), Bone marrow transplantation, 21, 1998, pp. 21-21
LOW ANTIBODY-RESPONSE IN A HEMOPHILIAC WITH NATURAL ANTI-VIII-C INHIBITORS TREATED WITH HDS AND AUTOGRAFT FOR A CONCOMITANT NON-HODGKINS-LYMPHOMA
Authors: SCHINCO PC TAMPONI G MONTARULLI B CARACCIOLO D TARELLA C
Citation: Pc. Schinco et al., LOW ANTIBODY-RESPONSE IN A HEMOPHILIAC WITH NATURAL ANTI-VIII-C INHIBITORS TREATED WITH HDS AND AUTOGRAFT FOR A CONCOMITANT NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 186-186
HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH PBPC AUTOGRAFT AS PRIMARY-TREATMENT IN LOW-INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA
Authors: TARELLA C CARACCIOLO D CORRADINI P GAVAROTTI P ZALLIO F BIANCHI A NOVERO D ROSSI G PILERI A
Citation: C. Tarella et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH PBPC AUTOGRAFT AS PRIMARY-TREATMENT IN LOW-INTERMEDIATE GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 612-612
HIGH-DOSE CHEMOTHERAPY AND PBPC AUTOGRAFTING IN INDOLENT LYMPHOMAS - EVALUATION OF MINIMAL RESIDUAL DISEASE AND MOLECULAR FOLLOW-UP
Authors: CORRADINI P ASTOLFI M CARACCIOLO D BONDESAN P VOENA C VITOLO U CINQUE F PILERI A TARELLA C
Citation: P. Corradini et al., HIGH-DOSE CHEMOTHERAPY AND PBPC AUTOGRAFTING IN INDOLENT LYMPHOMAS - EVALUATION OF MINIMAL RESIDUAL DISEASE AND MOLECULAR FOLLOW-UP, Bone marrow transplantation, 21, 1998, pp. 634-634
OVERALL TOXICITY AND LONG-TERM OUTCOME IN 120 AUTOTRANSPLANT PROCEDURES WITH MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: TARELLA C CARACCIOLO D CORRADINI P CASTELLINO C ZALLIO F TASSI W ROSSI G MASSAIA M FERRERO D BOCCADORO M PILERI A
Citation: C. Tarella et al., OVERALL TOXICITY AND LONG-TERM OUTCOME IN 120 AUTOTRANSPLANT PROCEDURES WITH MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS, Bone marrow transplantation, 21, 1998, pp. 690-690
ALLOGENEIC TRANSPLANTATION OF UNMANIPULATED PBSC IN PATIENTS WITH MULTIPLE-MYELOMA (MM)
Authors: MAJOLINO I CORRADINI P SCIME R SANTORO A TARELLA C CAVALLARO AM PALUMBO A INDOVINA A CARACCIOLO D BOCCADORO M MARCENO R PILERI A
Citation: I. Majolino et al., ALLOGENEIC TRANSPLANTATION OF UNMANIPULATED PBSC IN PATIENTS WITH MULTIPLE-MYELOMA (MM), Bone marrow transplantation, 21, 1998, pp. 743-743
HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION COMPARED WITH MACOP-B IN AGGRESSIVE B-CELL LYMPHOMA
Authors: GIANNI AM BREGNI M SIENA S BRAMBILLA C DINICOLA M LOMBARDI F GANDOLA L TARELLA C PILERI A RAVAGNANI F VALAGUSSA P BONADONNA G STERN AC MAGNI M CARACCIOLO D
Citation: Am. Gianni et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION COMPARED WITH MACOP-B IN AGGRESSIVE B-CELL LYMPHOMA, The New England journal of medicine, 336(18), 1997, pp. 1290-1297
MULTIPLE-MYELOMA - REDUCED PLASMA-CELL CONTAMINATION IN PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS PERFORMED AFTER REPEATED HIGH-DOSE CHEMOTHERAPY COURSES
Authors: OMEDE P TARELLA C PALUMBO A ARGENTINO C CARACCIOLO D CORRADINI P DOMINIETTO A GIARETTA F RAVAGLIA R TRIOLO R TRIOLO S PILERI A BOCCADORO M
Citation: P. Omede et al., MULTIPLE-MYELOMA - REDUCED PLASMA-CELL CONTAMINATION IN PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS PERFORMED AFTER REPEATED HIGH-DOSE CHEMOTHERAPY COURSES, British Journal of Haematology, 99(3), 1997, pp. 685-691
PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH PRIMARY REFRACTORY LYMPHOMA OR AT FIRST RELAPSE - COMPARISON WITH PATIENTS AT DIAGNOSIS AND IMPACT ON CLINICAL OUTCOME
Authors: TARELLA C CASTELLINO C CHERASCO C BONDESAN P GIARETTA F CORRADINI P CARACCIOLO D GAVAROTTI P PILERI A
Citation: C. Tarella et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH PRIMARY REFRACTORY LYMPHOMA OR AT FIRST RELAPSE - COMPARISON WITH PATIENTS AT DIAGNOSIS AND IMPACT ON CLINICAL OUTCOME, British Journal of Haematology, 99(1), 1997, pp. 41-46
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)
Authors: MAJOLINO I TARELLA C SCIME R SANTORO A CORRADINI P CAVALLARO AM PALUMBO A INDOVINA A CARACCIOLO D BOCCADORO M MARCENO R PILERI A
Citation: I. Majolino et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 4502-4502
LONG-TERM CLINICAL AND MOLECULAR FOLLOW-UP OF FOLLICULAR OR TRANSFORMED LYMPHOMA PATIENTS FOLLOWING FRONT-LINE HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY
Authors: TARELLA C CORRADINI P CARACCIOLO D GAVAROTTI P BIANCHI A ASTOLFI M ZAGLIO F PILERI A
Citation: C. Tarella et al., LONG-TERM CLINICAL AND MOLECULAR FOLLOW-UP OF FOLLICULAR OR TRANSFORMED LYMPHOMA PATIENTS FOLLOWING FRONT-LINE HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY, Blood, 90(10), 1997, pp. 501-501
FEASIBILITY AND EFFICACY OF NEGATIVE IN-VITRO PURGING ON MOBILIZED HEMATOPOIETIC PROGENITORS IN FOLLICULAR AND MANTLE-CELL LYMPHOMA PATIENTS TREATED WITH THE HDS REGIMEN
Authors: TARELLA C FERRERO D CORRADINI P ASTOLFI M BONDESAN P CARACCIOLO D CASTELLINO C CHERASCO C GIARETTA F MASSAIA M OMEDE P PILERI A
Citation: C. Tarella et al., FEASIBILITY AND EFFICACY OF NEGATIVE IN-VITRO PURGING ON MOBILIZED HEMATOPOIETIC PROGENITORS IN FOLLICULAR AND MANTLE-CELL LYMPHOMA PATIENTS TREATED WITH THE HDS REGIMEN, Blood, 90(10), 1997, pp. 954-954
MOLECULAR MONITORING OF MINIMAL RESIDUAL DISEASE IN FOLLICULAR AND MANTLE CELL NON-HODGKINS-LYMPHOMAS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL AUTOGRAFTING
Authors: CORRADINI P ASTOLFI M CHERASCO C LADETTO M VOENA C CARACCIOLO D PILERI A TARELLA C
Citation: P. Corradini et al., MOLECULAR MONITORING OF MINIMAL RESIDUAL DISEASE IN FOLLICULAR AND MANTLE CELL NON-HODGKINS-LYMPHOMAS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL AUTOGRAFTING, Blood, 89(2), 1997, pp. 724-731
HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY AS SALVAGE TREATMENT IN 33 PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA
Authors: TARELLA C CARACCIOLO D GAVAROTTI P CORRADINI P ZALLIO F CASTELLINO C PILERI A
Citation: C. Tarella et al., HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY AS SALVAGE TREATMENT IN 33 PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 3881-3881
HDS CHEMOTHERAPY AS UPFRONT TREATMENT IN 35 PATIENTS WITH INDOLENT LYMPHOMA INDUCES A HIGH-RATE OF DURABLE CLINICAL AND MOLECULAR REMISSION
Authors: TARELLA C CORRADINI P CARACCIOLO D ASTOLFI M CASTELLINO C GAVAROTTI P PILERI A
Citation: C. Tarella et al., HDS CHEMOTHERAPY AS UPFRONT TREATMENT IN 35 PATIENTS WITH INDOLENT LYMPHOMA INDUCES A HIGH-RATE OF DURABLE CLINICAL AND MOLECULAR REMISSION, Blood, 88(10), 1996, pp. 471-471
HEMATOLOGICAL SUPPORT OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY - CLINICAL-EVIDENCE FOR REDUCTION OF TOXICITY AND HIGH RESPONSE RATES IN POOR-RISK LYMPHOMAS
Authors: TARELLA C GAVAROTTI P CARACCIOLO D CORRADINI P CHERASCO C CASTELLINO C GALLO E PILERI A
Citation: C. Tarella et al., HEMATOLOGICAL SUPPORT OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY - CLINICAL-EVIDENCE FOR REDUCTION OF TOXICITY AND HIGH RESPONSE RATES IN POOR-RISK LYMPHOMAS, Annals of oncology, 6, 1995, pp. 3-8
CIRCULATING PROGENITORS FOLLOWING HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY WITH G-CSF - SHORT INTERVALS BETWEEN DRUG COURSES SEVERELY IMPAIRPROGENITOR MOBILIZATION
Authors: TARELLA C CARACCIOLO D GAVAROTTI P BONDESAN P CHERASCO C OMEDE P BREGNI M SIENA S GIANNI AM PILERI A
Citation: C. Tarella et al., CIRCULATING PROGENITORS FOLLOWING HIGH-DOSE SEQUENTIAL (HDS) CHEMOTHERAPY WITH G-CSF - SHORT INTERVALS BETWEEN DRUG COURSES SEVERELY IMPAIRPROGENITOR MOBILIZATION, Bone marrow transplantation, 16(2), 1995, pp. 223-228
BOTH EARLY AND COMMITTED HEMATOPOIETIC PROGENITORS ARE MORE FREQUENT IN PERIPHERAL-BLOOD THAN IN BONE-MARROW DURING MOBILIZATION INDUCED BYHIGH-DOSE CHEMOTHERAPY PLUS G-CSF
Authors: TARELLA C BENEDETTI G CARACCIOLO D CASTELLINO C CHERASCO C BONDESAN P OMEDE P RUGGIERI D GIANNI AM PILERI A
Citation: C. Tarella et al., BOTH EARLY AND COMMITTED HEMATOPOIETIC PROGENITORS ARE MORE FREQUENT IN PERIPHERAL-BLOOD THAN IN BONE-MARROW DURING MOBILIZATION INDUCED BYHIGH-DOSE CHEMOTHERAPY PLUS G-CSF, British Journal of Haematology, 91(3), 1995, pp. 535-543
HIGH-DOSE (HDS) CHEMOTHERAPY AND PBPC AUTOGRAFTING IN LOW-GRADE AND INTERMEDIATE-GRADE B-CELL LYMPHOMAS - ANALYSIS OF MINIMAL RESIDUAL DISEASE AND MOLECULAR FOLLOW-UP
Authors: CORRADINI P ASTOLFI M CARACCIOLO D BONDESAN P CHERASCO C PILERI A TARELLA C
Citation: P. Corradini et al., HIGH-DOSE (HDS) CHEMOTHERAPY AND PBPC AUTOGRAFTING IN LOW-GRADE AND INTERMEDIATE-GRADE B-CELL LYMPHOMAS - ANALYSIS OF MINIMAL RESIDUAL DISEASE AND MOLECULAR FOLLOW-UP, Blood, 86(10), 1995, pp. 3229-3229
FEASIBILITY AND TOXICITY OF HIGH-DOSE CHEMOTHERAPY WITH GROWTH-FACTORAND CIRCULATING PROGENITOR SUPPORT - THE EXPERIENCE IN 111 PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS
Authors: TARELLA C CARACCIOLO D GAVAROTTI P CORRADINI P CASTELLINO C CHERASCO C BIANCHI A MASSAIA M PALUMBO A BOCCADORO M PILERI A
Citation: C. Tarella et al., FEASIBILITY AND TOXICITY OF HIGH-DOSE CHEMOTHERAPY WITH GROWTH-FACTORAND CIRCULATING PROGENITOR SUPPORT - THE EXPERIENCE IN 111 PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS, Blood, 86(10), 1995, pp. 3857-3857
HIGH-DOSE (HD) CHEMOTHERAPY AND AUTOGRAFT WITH PERIPHERAL PROGENITORSAS FIRST-LINE TREATMENT IN MULTIPLE-MYELOMA - HIGH EFFICACY IN PATIENTS WITH HIGH PLASMA-CELL PROLIFERATIVE ACTIVITY
Authors: TARELLA C BOCCADORO M CORRADINI P CARACCIOLO D PALUMBO A ARGENTINO C LOMBARDI F BREGNI M SIENA S GIANNI AM PILERI A
Citation: C. Tarella et al., HIGH-DOSE (HD) CHEMOTHERAPY AND AUTOGRAFT WITH PERIPHERAL PROGENITORSAS FIRST-LINE TREATMENT IN MULTIPLE-MYELOMA - HIGH EFFICACY IN PATIENTS WITH HIGH PLASMA-CELL PROLIFERATIVE ACTIVITY, Blood, 86(10), 1995, pp. 3858-3858
HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY, A WIDELY APPLICABLE REGIMEN, CONFERS SURVIVAL BENEFIT TO PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA
Authors: GIANNI AM TARELLA C BREGNI M SIENA S LOMBARDI F GANDOLA L CARACCIOLO D STERN A BONADONNA G BOCCADORO M PILERI A
Citation: Am. Gianni et al., HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY, A WIDELY APPLICABLE REGIMEN, CONFERS SURVIVAL BENEFIT TO PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA, Journal of clinical oncology, 12(3), 1994, pp. 503-509
Risultati: 1-25 | 26-30